Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

1(14%)

Results Posted

67%(2 trials)

Phase Distribution

Ph not_applicable

86%

Ph phase_1

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

1(14.3%)

N/ANon-phased studies

6(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Other(2)

Detailed Status

Completed3

unknown2

Enrolling by invitation1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (14.3%)

N/A6 (85.7%)

Trials by Status

completed343%

enrolling_by_invitation114%

recruiting114%

unknown229%

Recent Activity

1 active trials

Showing 5 of 7

enrolling_by_invitationnot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT04691518Not Applicable

Effect of Intermittent Hypoxia in Healthy Individuals

Enrolling By Invitation

NCT06390930Not Applicable

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Recruiting

NCT03645031Not Applicable

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Completed

NCT05341466Not Applicable

The Effect of Acute Intermittent Hypoxia on Motor Learning

Completed

NCT05164705Not Applicable

Improving Human Cerebrovascular Function Using Acute Intermittent Hypoxia

Completed

NCT03774043Phase 1

Timing and Dosage of Acute Intermittent Hypoxia in Persons With SCI

Unknown

NCT03262766Not Applicable

Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI

Unknown

All 7 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 7